Metropolitan Life Insurance Company (MetLife)’s 908 Devices MASS Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio MASS Stock Details MASS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,440	Closed	-$10.9K	–	1230
2024 Q1	$10.9K	Hold	1,440	–	–	﹤0.01%	2105
2023 Q4	$16.2K	Hold	1,440	–	–	﹤0.01%	2006
2023 Q3	$9.59K	Hold	1,440	–	–	﹤0.01%	2231
2023 Q2	$9.88K	Hold	1,440	–	–	﹤0.01%	2307
2023 Q1	$12.4K	Hold	1,440	–	–	﹤0.01%	2083
2022 Q4	$11K	Hold	1,440	–	–	﹤0.01%	2259
2022 Q3	$23.7K	Hold	1,440	–	–	﹤0.01%	1937
2022 Q2	$29.6K	Hold	1,440	–	–	﹤0.01%	1825
2022 Q1	$27.4K	Sell	1,440 -4,275	-75%	-$73.5K	﹤0.01%	1935
2021 Q4	$148K	Buy	5,715 +1,822	+47%	+$53.6K	﹤0.01%	2231
2021 Q3	$127K	Buy	+3,893	New	+$132K	﹤0.01%	2386
2021 Q2	–	Sell	-2,701	Closed	-$131K	–	2808
2021 Q1	$131K	Buy	+2,701	New	+$154K	﹤0.01%	2300

Other funds holding MASS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

ITP

Iron Triangle Partners Cos Cob, Connecticut $875M AUM 49.85% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TCM

Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s MASS Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of 908 Devices (MASS) in Q2 2024, closing a stake of 1,440 shares — an estimated $10.9K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in MASS in Q1 2021 and held it in 12 quarters. The position peaked at $148K in Q4 2021. 90 funds tracked by Wall St. Rank hold MASS as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining 908 Devices position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,440 908 Devices shares in Q2 2024, an estimated $10.9K.
Metropolitan Life Insurance Company (MetLife) first reported a position in 908 Devices in Q1 2021 and held it in 12 quarters.
Metropolitan Life Insurance Company (MetLife)'s 908 Devices position peaked at $148K in Q4 2021.
90 funds tracked by Wall St. Rank held 908 Devices as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.